FOXO4
Forkhead box protein O4 (FOXO4) is a protein that in humans is encoded by the FOXO4 gene. This protein is part of the forkhead box (FOX) family of transcription factors, which are involved in the regulation of gene expression related to cellular processes such as cell cycle control, apoptosis, and metabolism.
Function[edit]
FOXO4 is a member of the O subclass of forkhead transcription factors, which play a critical role in the regulation of oxidative stress responses, longevity, and tumor suppression. FOXO4 is known to be involved in the insulin signaling pathway, where it acts as a downstream effector that can influence glucose metabolism and insulin sensitivity.
Clinical significance[edit]
Alterations in FOXO4 activity have been associated with various diseases, including cancer and diabetes mellitus. In cancer, FOXO4 can function as a tumor suppressor by inducing cell cycle arrest and apoptosis in response to DNA damage. However, its activity can be inhibited by oncogenic signaling pathways, such as the PI3K/AKT pathway, which leads to its phosphorylation and subsequent nuclear exclusion.
In the context of aging, FOXO4 has been implicated in the regulation of cellular senescence, a process that contributes to age-related diseases. Recent studies have explored the potential of targeting FOXO4 to selectively eliminate senescent cells, thereby improving healthspan and lifespan.
Interactions[edit]
FOXO4 interacts with several other proteins to exert its functions. It can form complexes with 14-3-3 proteins, which regulate its subcellular localization and activity. Additionally, FOXO4 can interact with SMAD proteins to modulate transforming growth factor-beta (TGF-β) signaling.
See also[edit]
References[edit]
External links[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian